Sign up to save your podcasts
Or
Share Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP
Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies.
View all episodes
By TheBrief.HealthPost hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies.